5Patrono C,Bachmann F,Baigent C,et al.European Society of Cardiology.Expert consensus document on the use of antiplatelet agents.The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology.Eur Heart J,2004,25:166-181.
6Eagle KA,Guyton RA,Davidoff R,et al.American College of Cardiology.American Heart Association Task Force on Practice Guidelines.American Society for Thoracic Surgery and the Society of Thoracic Surgeons.ACC/AHA 2004 guideline update for coronary artery bypass graft surgery:summary article:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).Circulation,2004,110:1168-1176.
7Stein PD,Alpert JS,Bussey HI,et al.Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.Chest,2001,119:2205-2275.
8Chen ZM,Jiang LX,Chen YP,et al.COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group.Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction:randomised placebo-controlled trial.Lancet,2005,366:1607-1621.
9Patrono C,Coller B,FitzGerald GA,et al.Platelet-active drugs:the relationships among dose,effectiveness,and side effects:the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.Chest,2004,126(3 Suppl):234S-264S.
10Pearson TA,Blair SN,Daniels SR,et al.AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke:2002 Update:Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases.American Heart Association Science Advisory and Coordinating Committee.Circulation,2002,106:388-391.
